Alzheimer’s and Parkinson’s beneath the microscope A detailed dialogue by top researches in the field into current Alzheimer’s and Parkinson’s analysis features as article of the month in the prestigious journal, Character Critiques Neuroscience . In the article they review what we have learned from disease types of Alzheimer’s and related dementias, and specifically how they have contributed to the early diagnosis and the prospect of cure strategy. They discuss their groundbreaking work also, as well as research by others which has led to the identification of novel players and promising medication targets. Current treatment techniques include vaccination, anti-inflammatory medications, and modulators for development, aggregation and clearance of toxic proteins that accumulate in the brains of Alzheimer patients.

A unique feature of pyrosequencing technology is usually its capability to quantify DNA methylation, as found in quantification of methylation frequencies for consecutive CpG sites. Quantification of DNA methylation can be done at each CpG site or at regional methylation levels ( High-quality sequence evaluation of CpG methylation was lately recognized as important in cancer study: scientists using pyrosequencing technology could actually distinguish tumor-particular methylation for multiple malignancy connected genes including p16, MGMT, and CYGB.. Labs introduces pyrosequencing providers for hospitals Altogen, research institutions Altogen Labs item.